Loading...
Dr.reddy's Laboratories Ltd — Guaifenesin Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #10 for Guaifenesin · $572.2K export value · DGFT Verified
Dr.reddy's Laboratories Ltd is the #10 Indian exporter of Guaifenesin with $572.2K in export value and 33 verified shipments. Dr.reddy's Laboratories Ltd holds a 2.1% market share in Guaifenesin exports across 1 countries.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $18.6M | 464 | 75.6% |
| IRAQ | $915.0K | 33 | 3.7% |
| RUSSIA | $841.3K | 34 | 3.4% |
| FIJI | $686.5K | 16 | 2.8% |
| UNITED ARAB EMIRATES | $429.7K | 15 | 1.7% |
| TURKMENISTAN | $410.7K | 21 | 1.7% |
| TANZANIA | $401.7K | 21 | 1.6% |
| KENYA | $363.9K | 31 | 1.5% |
| MYANMAR | $310.6K | 12 | 1.3% |
| CAMBODIA | $309.5K | 26 | 1.3% |
India exports Guaifenesin to 77 countries. The top destination is UNITED STATES (75.6%), followed by IRAQ and RUSSIA.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| GRANULES CONSUMER HEALTH | UNITED STATES | $5.8M | 116 |
| SPIRIT PHARMACEUTICALS LLC | UNITED STATES | $1.8M | 36 |
| GRANULES USA INC. | UNITED STATES | $905.1K | 25 |
| AGIO RUS LLC | RUSSIA | $837.4K | 33 |
| IBN SINA SCIENTIFIC BUREAU | IRAQ | $758.9K |
India exported $19.9M worth of Guaifenesin through 1,050 shipments from 151 suppliers to 77 countries, serving 278 buyers globally. Dr.reddy's Laboratories Ltd contributes $572.2K to this total, accounting for 2.1% of India's Guaifenesin exports.
Dr.reddy's Laboratories Ltd's average Guaifenesin shipment value is $17.3K per consignment, based on 33 shipments totaling $572.2K.
Dr.reddy's Laboratories Ltd ranks #10 among 151 Indian Guaifenesin exporters with a 2.1% market share. The top 3 exporters are GRANULES INDIA LIMITED ($9.1M), ELYSIUM PHARMACEUTICALS LTD ($3.9M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($899.7K). Dr.reddy's Laboratories Ltd processed 33 shipments to 1 destination countries.
What Dr.reddy's Laboratories Ltd must comply with to export Guaifenesin to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | GLENMARK PHARMACEUTICALS LIMITED | $594.8K | 30 | 7 | $19.8K |
| 9 | MARKSANS PHARMA LIMITED | $576.5K | 28 | 3 | $20.6K |
| 10 | DR.REDDY'S LABORATORIES LTD ★ | $572.2K | 33 | 1 | $17.3K |
| 11 | ELYSIUM PHARMACEUTICALS LIMITED | $566.3K | 14 | 1 |
| Port | Shipments | % Share |
|---|---|---|
| HYDERABAD ICD | 118 | 11.2% |
| NHAVA SHEVA SEA (INNSA1) | 94 | 9.0% |
| JNPT | 74 | 7.0% |
| JNPT/ NHAVA SHEVA SEA | 70 | 6.7% |
| HYDERABAD AIR | 53 | 5.0% |
| HYDERABAD ICD (INSNF6) | 50 | 4.8% |
| MUNDRA SEA (INMUN1) | 50 | 4.8% |
| MUNDRA SEA | 47 | 4.5% |
Latest developments and market context
Detailed market intelligence for Guaifenesin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Dr.reddy's Laboratories Ltd's Guaifenesin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
| 22 |
| SHREE HARI INTERNATIONAL LLC | UNITED STATES | $665.9K | 24 |
| GRANULES USA INC | UNITED STATES | $643.6K | 15 |
| PERRIGO COMPANY | UNITED STATES | $600.0K | 12 |
| PRODOSE INC. | UNITED STATES | $500.0K | 10 |
| MAKANS LIMITED | FIJI | $350.0K | 7 |
India's Guaifenesin is purchased by 278 buyers worldwide. The top buyer is GRANULES CONSUMER HEALTH (UNITED STATES), followed by SPIRIT PHARMACEUTICALS LLC and GRANULES USA INC..
| $40.5K |
| 12 | CADILA PHARMACEUTICALS LIMITED | $419.5K | 18 | 4 | $23.3K |
Dr.reddy's Laboratories Ltd ranks #10 among 151 Indian Guaifenesin exporters. Average shipment value of $17.3K compared to the market average of $131.8K. The closest competitors by value are GLENMARK PHARMACEUTICALS LIMITED and MARKSANS PHARMA LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 77+ countries, 278+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Dr.reddy's Laboratories Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Guaifenesin. For current shipment-level data, contact TransData Nexus.